Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9400
+0.0040 (0.43%)
Aug 18, 2026, 9:07 AM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 40.43 million as of August 17, 2026. Its market cap has increased by 53.41% in one year.
Market Cap
40.43M
Enterprise Value
41.30M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.94
ChartMarket Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 40.43M, a decrease of -87.63%. That is a compound annual growth rate of -28.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 40.43M | -36.76% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| Gubra | 6.07B |
| BioPorto | 591.66M |
| ViroGates | 101.17M |
| Pharma Equity Group | 100.17M |